Drug Database
Back to search

Netherlands· NL-547ad791cb17

Hexvix 85 mg, poeder en oplosmiddel voor oplossing voor intravesicaal gebruik

A hexaminolevulinate product containing hexaminolevulinaathydrochloride, registered in Netherlands by PhotoCure ASA. The same ATC class is registered in 11 of our 19 countries.

ATC V04CX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedHexvix 85 mg, poeder en oplosmiddel v…ATCV04CX06REGISTER NO.NL-547ad791cb17PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hexaminolevulinaathydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hexaminolevulinate is registered in 11 of 19 countries.

Countries holding a registration under ATC V04CX06 (hexaminolevulinate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search hexaminolevulinate products by name

Hexaminolevulinate · ATC V04CX06

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HEXAMINOLEVULINAATHYDROCHLORIDE
Manufacturer
PhotoCure ASA
Country
Netherlands (NL)
ATC code
V04CX06
ATC class
Hexaminolevulinate
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    31914

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for hexaminolevulinate.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hexaminolevulinate against other medicinesHow interaction checks work

Hexaminolevulinate · interactions on record

1 record

  • 1 severe

Most severe, free to view

  • ValrubicinL01DB09severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hexaminolevulinate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hexaminolevulinate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Hexvix
  • Belgium · Hexvix
  • Czechia · Hexvix
  • Germany · Hexvix
  • Denmark · Hexvix
  • Estonia · Hexvix
  • Spain · Hexvix
  • Finland · Hexvix
  • France · Hexvix
  • United Kingdom (Northern Ireland) · Hexvix
  • Greece · Hexvix
  • Hungary · Hexvix
  • Ireland · Hexvix
  • Iceland · Hexvix
  • Italy · Hexvix
  • Lithuania · Hexvix
  • Latvia · Hexvix
  • Norway · Hexvix
  • Poland · Hexvix
  • Portugal · Hexvix
  • Sweden · Hexvix
  • Slovenia · Hexvix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/887a9c99-50b8-4a4a-a3a4-bc6b89250d1e
GET /v1/drugs/887a9c99-50b8-4a4a-a3a4-bc6b89250d1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor intravesicaal gebruik",
  "route": "Intravesicaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31914_smpc.pdf",
  "strength": null,
  "atc_label": "Hexaminolevulinate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg31914",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "HEXAMINOLEVULINAATHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h31914.pdf",
  "authorised_at": "2005/07/27",
  "procedure_number": "SE/H/0478/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "31914",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about hexaminolevulinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console